Pass the NU 578 Unit 3 Advanced Pharmacology Exam on your first attempt with the most current actual exam resource available. This A+ Graded comprehensive study resource contains 75 Questions with Verified Answers and Expert Rationales fully aligned with the University of South Alabama NU 578 Advanced Pharmacology curriculum, covering all advanced pharmacology domains required for graduate-level nursing success. Designed to mirror the official NU 578 Unit 3 Examination format, this resource provides the most thorough preparation for advanced practice nursing students seeking to demonstrate mastery of pharmacotherapeutics, pharmacokinetics, pharmacodynamics, and clinical prescribing principles. Comprehensive content coverage includes: Pharmacokinetics & Pharmacodynamics: Absorption (bioavailability, first-pass effect, routes of administration), distribution (protein binding, volume of distribution, blood-brain barrier), metabolism (Phase I and Phase II reactions, CYP450 enzyme system, first-order vs. zero-order kinetics, genetic polymorphisms), excretion (renal clearance, glomerular filtration, tubular secretion, half-life), pharmacodynamics (receptor theory, agonists, antagonists, partial agonists, dose-response relationships, therapeutic index, potency vs. efficacy) Pharmacotherapeutics Across the Lifespan: Pediatric pharmacology (developmental considerations, weight-based dosing, organ maturation, FDA-approved pediatric indications, off-label use, adverse reactions), geriatric pharmacology (polypharmacy, age-related physiological changes, altered pharmacokinetics, Beers Criteria, START/STOPP criteria, medication safety), pregnancy and lactation pharmacology (FDA pregnancy categories, placental transfer, teratogenicity, lactation risk categories, medication safety during breastfeeding) Cardiovascular Pharmacology: Antihypertensive agents (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, diuretics, alpha-blockers, centrally acting agents), heart failure medications (digoxin, loop diuretics, beta-blockers, ACE inhibitors, ARBs, ARNI, hydralazine, nitrates), antiarrhythmic agents (Vaughan-Williams classification, amiodarone, lidocaine, beta-blockers, calcium channel blockers), antianginal agents (nitrates, beta-blockers, calcium channel blockers), antithrombotic agents (antiplatelets: aspirin, clopidogrel, ticagrelor; anticoagulants: warfarin, heparin, LMWH, direct oral anticoagulants), lipid-lowering agents (statins, ezetimibe, PCSK9 inhibitors, fibrates, niacin) Respiratory Pharmacology: Asthma and COPD medications (beta-2 agonists: SABA, LABA; anticholinergics: ipratropium, tiotropium; inhaled corticosteroids; combination inhalers; leukotriene modifiers; mast cell stabilizers; methylxanthines; systemic corticosteroids), antitussives, expectorants, mucolytics, pulmonary arterial hypertension medications Endocrine Pharmacology: Diabetes medications (insulins: rapid-acting, short-acting, intermediate-acting, long-acting, premixed; oral antidiabetics: metformin, sulfonylureas, meglitinides, thiazolidinediones, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, alpha-glucosidase inhibitors), thyroid medications (levothyroxine, liothyronine, methimazole, propylthiouracil), adrenal medications (glucocorticoids, mineralocorticoids), reproductive hormones (estrogens, progestins, testosterone, contraceptives), osteoporosis medications (bisphosphonates, denosumab, calcitonin, teriparatide, RANKL inhibitors) Neurological & Psychiatric Pharmacology: Antidepressants (SSRIs, SNRIs, TCAs, MAOIs, atypical antidepressants), anxiolytics (benzodiazepines, buspirone), antipsychotics (first-generation/typical, second-generation/atypical, clozapine monitoring), mood stabilizers (lithium, valproate, carbamazepine, lamotrigine), anticonvulsants (phenytoin, levetiracetam, valproate, carbamazepine, lamotrigine, gabapentin), antiparkinson agents (levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors), Alzheimer's medications (cholinesterase inhibitors: donepezil, rivastigmine, galantamine; memantine), sedative-hypnotics (benzodiazepines, Z-drugs: zolpidem, eszopiclone, zaleplon; melatonin agonists, orexin receptor antagonists) Infectious Disease Pharmacology: Antibiotic classes (penicillins, cephalosporins, carbapenems, monobactams, macrolides, tetracyclines, aminoglycosides, fluoroquinolones, sulfonamides, oxazolidinones, lipopeptides, glycylcyclines), antimicrobial stewardship principles, antibiotic resistance mechanisms, antifungal agents (azoles, echinocandins, polyenes, allylamines), antiviral agents (influenza, HIV, hepatitis, herpes), antiretroviral therapy (NRTIs, NNRTIs, PIs, integrase inhibitors, entry inhibitors), antitubercular agents, anti-parasitic agents Pain Management & Analgesics: Opioid analgesics (morphine, hydromorphone, fentanyl, oxycodone, hydrocodone, methadone, tramadol), opioid equianalgesic dosing, opioid conversion, opioid side effects management, opioid use disorder treatment (buprenorphine, methadone, naltrexone), non-opioid analgesics (NSAIDs, acetaminophen), adjuvant analgesics (antidepressants, anticonvulsants, corticosteroids, topical agents), multimodal analgesia Oncology Pharmacology: Chemotherapeutic agents (alkylating agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents), targeted therapies (tyrosine kinase inhibitors, monoclonal antibodies), immunotherapy (immune checkpoint inhibitors, CAR-T cells), supportive care medications (antiemetics, growth factors, bisphosphonates), chemotherapy adverse effect management Immunologic & Biologic Agents: Vaccines (live attenuated, inactivated, subunit, toxoid, conjugate, mRNA), immunization schedules (ACIP, CDC), immunosuppressants (calcineurin inhibitors, mTOR inhibitors, corticosteroids, antimetabolites, biologics), monoclonal antibodies (indications, mechanisms, adverse effects) Substance Use Disorder Pharmacology: Alcohol use disorder (disulfiram, naltrexone, acamprosate), opioid use disorder (methadone, buprenorphine, naltrexone), nicotine dependence (nicotine replacement, varenicline, bupropion) Drug Interactions & Adverse Effects: Drug-drug interactions, drug-food interactions, drug-herb interactions, adverse drug reactions, adverse event reporting, medication error prevention, high-alert medications, black box warnings, QT prolongation monitoring Clinical Prescribing Principles: Prescription writing, medication reconciliation, therapeutic drug monitoring, patient education, adherence strategies, cultural considerations in prescribing, ethical prescribing, controlled substance regulations (DEA schedules, prescription monitoring programs) Each question includes verified answers with expert rationales explaining the "why" behind correct and incorrect answers, reinforcing pharmacokinetic principles, pharmacodynamic mechanisms, clinical prescribing decisions, and evidence-based pharmacotherapy essential for NU 578 success. Backed by our Pass Guarantee, this comprehensive NU 578 Unit 3 Exam resource delivers the ultimate preparation for University of South Alabama advanced pharmacology students. Download now for instant access and pass with confidence.
Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.
No worries! You can instantly pick a different document that better fits what you're looking for.
No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.
“Bought, downloaded, and aced it. It really can be that simple.”
